Chemoinformaics analysis of trans-Propenyl propyl disulfide
Molecular Weight | 148.296 | nRot | 4 |
Heavy Atom Molecular Weight | 136.2 | nRig | 1 |
Exact Molecular Weight | 148.038 | nRing | 0 |
Solubility: LogS | -3.473 | nHRing | 0 |
Solubility: LogP | 3.203 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 23.8215 |
nHD | 0 | BPOL | 14.4985 |
QED | 0.443 |
Synth | 3.844 |
Natural Product Likeliness | 2.162 |
NR-PPAR-gamma | 0.151 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.008 |
CACO-2 | -4.244 |
MDCK | 0.0000208 |
BBB | 0.874 |
PPB | 0.926898 |
VDSS | 3.002 |
FU | 0.0665524 |
CYP1A2-inh | 0.966 |
CYP1A2-sub | 0.9 |
CYP2c19-inh | 0.888 |
CYP2c19-sub | 0.808 |
CYP2c9-inh | 0.265 |
CYP2c9-sub | 0.877 |
CYP2d6-inh | 0.483 |
CYP2d6-sub | 0.862 |
CYP3a4-inh | 0.077 |
CYP3a4-sub | 0.226 |
CL | 12.766 |
T12 | 0.346 |
hERG | 0.006 |
Ames | 0.369 |
ROA | 0.064 |
SkinSen | 0.952 |
Carcinogencity | 0.125 |
EI | 0.995 |
Respiratory | 0.969 |
NR-Aromatase | 0.042 |
Antiviral | No |
Prediction | 0.950833 |